Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Dengjie Ouyang"'
Autor:
Zhecheng Li, Yaxin Zhao, Peng Huang, Zhaoyi Wu, Dengjie Ouyang, Adolphus Osei Nyarko, Lei Ai, Zhejia Zhang, Shi Chang
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-20 (2024)
Abstract ATAD2 (ATPase Family AAA Domain-Containing 2) is highly expressed across varies tumor types, yet its common roles in tumor progression and immune interaction remain unclear. We analyzed the expression and alteration profiles of ATAD2, along
Externí odkaz:
https://doaj.org/article/8d4d1a984c09419c807ec656469e6b26
Autor:
Hongyu Gao, Dengjie Ouyang, Xinyu Guan, Jiachi Xu, Qitong Chen, Liyun Zeng, Jian Pang, Qiongyan Zou, Ke Qian, Wenjun Yi
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background In the context of breast cancer (BC), the correlation between lymphocytes and clinical outcomes, along with treatment response, has garnered attention. Despite this, few investigations have delved into the interplay among distinct
Externí odkaz:
https://doaj.org/article/afb418acfcf94f748721cb01ba69a226
Autor:
Dengjie Ouyang, Tao Hong, Mengdie Fu, Yitong Li, Liyun Zeng, Qitong Chen, Hongye He, Ying Wen, Yan Cheng, Meirong Zhou, Qiongyan Zou, Wenjun Yi
Publikováno v:
Breast Cancer Research, Vol 25, Iss 1, Pp 1-17 (2023)
Abstract Background Chemotherapy is an important strategy for the treatment of hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+HER2−) breast cancer (BC), but this subtype has a low response rate to chemotherapy. Grow
Externí odkaz:
https://doaj.org/article/93ad3a6173c74ab585ae872855820a22
Autor:
Na Luo, Ying Wen, Qiongyan Zou, Dengjie Ouyang, Qitong Chen, Liyun Zeng, Hongye He, Munawar Anwar, Limeng Qu, Jingfen Ji, Wenjun Yi
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract The current diagnostic technologies for assessing the axillary lymph node metastasis (ALNM) status accurately in breast cancer (BC) remain unsatisfactory. Here, we developed a diagnostic model for evaluating the ALNM status using a combinati
Externí odkaz:
https://doaj.org/article/16aa7bf5029c4cd2b284bc0a5f93ee75
Autor:
Qitong Chen, Dengjie Ouyang, Munawar Anwar, Ning Xie, Shouman Wang, Peizhi Fan, Liyuan Qian, Gannong Chen, Enxiang Zhou, Lei Guo, Xiaowen Gu, Boni Ding, Xiaohong Yang, Liping Liu, Chao Deng, Zhi Xiao, Jing Li, Yunqi Wang, Shan Zeng, Jinhui Hu, Wei Zhou, Bo Qiu, Zhongming Wang, Jie Weng, Mingwen Liu, Yi Li, Tiegang Tang, Jianguo Wang, Hui Zhang, Bin Dai, Wuping Tang, Tao Wu, Maoliang Xiao, Xiantao Li, Hailong Liu, Lai Li, Wenjun Yi, Quchang Ouyang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Externí odkaz:
https://doaj.org/article/8f47dfb6ab9a465cb3239f122ee82323
Autor:
Qitong Chen, Dengjie Ouyang, Munawar Anwar, Ning Xie, Shouman Wang, Peizhi Fan, Liyuan Qian, Gannong Chen, Enxiang Zhou, Lei Guo, Xiaowen Gu, Boni Ding, Xiaohong Yang, Liping Liu, Chao Deng, Zhi Xiao, Jing Li, Yunqi Wang, Shan Zeng, Jinhui Hu, Wei Zhou, Bo Qiu, Zhongming Wang, Jie Weng, Mingwen Liu, Yi Li, Tiegang Tang, Jianguo Wang, Hui Zhang, Bin Dai, Wuping Tang, Tao Wu, Maoliang Xiao, Xiantao Li, Hailong Liu, Lai Li, Wenjun Yi, Quchang Ouyang
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: Pyrotinib, an irreversible pan-ERBB inhibitor, has shown promising antitumour activity, and acceptable tolerability. This research was conducted to evaluate the actual use and effectiveness of pyrotinib in China, therefore, contributed to
Externí odkaz:
https://doaj.org/article/e32a29a0bdc949c79ff4238792b3eb43
Autor:
Ying Wen, Dengjie Ouyang, Qitong Chen, Liyun Zeng, Na Luo, Hongye He, Munawar Anwar, Limeng Qu, Qiongyan Zou, Wenjun Yi
Publikováno v:
Gland Surgery. 11:100-114
Autor:
Lei Ai, Hui-Yu Hu, Hai-Long Tan, Zi-en Qin, Shi Chang, Pei Chen, Bo Wei, Dengjie Ouyang, Peng Huang, Ya-Xin Zhao, Ning Li, Mian Liu
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 24, Pp 8829-8837 (2021)
Cancer Medicine, Vol 10, Iss 24, Pp 8829-8837 (2021)
Purpose Marital status has emerged as an important influence on several cancer outcomes, but its role in medullary thyroid cancer (MTC) remains unclear. This study was to explore the effects of marital status on the prognosis of MTC patients and to d
Autor:
Wuping Tang, Yi Li, Wei Zhou, Jinhui Hu, Bin Dai, Liyuan Qian, Hui Zhang, Zhi Xiao, Jianguo Wang, Tao Wu, Shouman Wang, Yunqi Wang, Q. Chen, Tiegang Tang, Xiaohong Yang, Jie Weng, Munawar Anwar, Dengjie Ouyang, Liping Liu, Peizhi Fan, Ning Xie, Maoliang Xiao, Xiaowen Gu, Jing Li, Bo Qiu, Zhongming Wang, Quchang Ouyang, Shan Zeng, Enxiang Zhou, Wenjun Yi, Chao Deng, Hailong Liu, Xiantao Li, Boning Ding, Lai Li, Lei Guo, Mingwen Liu, Gannong Chen
Publikováno v:
Clinical Cancer Research. 27:4634-4641
Purpose: Patients with HER2-positive (HER2+) metastatic breast cancer (MBC) have poor prognoses. Pyrotinib has shown promising antitumor activity in MBC to improve progression-free survival (PFS). However, findings based on real-world data to analyze
Autor:
Peng Huang, Dengjie Ouyang, Pei Chen, Rooh-Afza Khushbu, Mian Liu, Hai-Long Tan, Shi Chang, Hui-Yu Hu
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 147:323-337
The incidence of papillary thyroid cancer (PTC), the major type of thyroid cancer, is increasing rapidly around the world, and its pathogenesis is still unclear. There is poor prognosis for PTC involved in rapidly progressive tumors and resistance to